Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFILZOMIB vs CARTEOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARFILZOMIB vs CARTEOLOL: Safety Overview

Metric CARFILZOMIB CARTEOLOL
Total FAERS Reports 21,814 318
Deaths Reported 3,448 30
Death Rate 15.8% 9.4%
Hospitalizations 7,502 93
Average Patient Age 64.7 yrs 67.5 yrs
% Female Patients 42.6% 56.6%
FDA Approval Date Jul 20, 2012 Dec 28, 1988
Manufacturer Onyx Pharmaceuticals, Inc. Sandoz Inc
Route INTRAVENOUS OPHTHALMIC
Marketing Status Prescription Discontinued